Elevated C-reactive protein and posttraumatic stress pathology among survivors of the 9/11 World Trade Center attacks

Journal of Psychiatric Research

Volumn 89, Issue , 2017, Pages 14-21

  Rosen, Rebecca L ^a,b   Levy Carrick, Nomi ^a,b   Reibman, Joan ^a,b   Xu, Ning ^a   Shao, Yongzhao ^a,b   Liu, Mengling ^a,b   Ferri, Lucia ^a,b   Kazeros, Angeliki ^a,b   Caplan Shaw, Caralee E ^a,b   Pradhan, Deepak R ^a,b   Marmor, Michael ^a,b   Galatzer Levy, Isaac R ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BELLEVUE HOSPITAL CENTER   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

C reactive protein; Depression; PTSD; Systemic inflammation; Trauma; World Trade Center

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANXIETY; AROUSAL; ARTICLE; ATOMIC BOMB SURVIVOR; AVOIDANCE BEHAVIOR; BODY MASS; COHORT ANALYSIS; DEPRESSION; DISASTER; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MIDDLE AGED; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; TERRORISM; METABOLISM; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; QUESTIONNAIRE; RESPIRATION DISORDERS; STRESS DISORDERS, POST-TRAUMATIC; SURVIVOR;

ADULT; ANXIETY; C-REACTIVE PROTEIN; COHORT STUDIES; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RESPIRATION DISORDERS; SEPTEMBER 11 TERRORIST ATTACKS; STRESS DISORDERS, POST-TRAUMATIC; SURVEYS AND QUESTIONNAIRES; SURVIVORS;

EID: 85010738956     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2017.01.007     Document Type: Article

References (55)

1. Baker, D.G., Nievergelt, C.M., O'Connor, D.T., Biomarkers of PTSD: neuropeptides and immune signaling. Neuropharmacology 62:2 (2012), 663–673.
2. Brackbill, R.M., Hadler, J.L., DiGrande, L., Ekenga, C.C., Farfel, M.R., Friedman, S., Perlman, S.E., Stellman, S.D., Walker, D.J., Wu, D., Yu, S., Thorpe, L.E., Asthma and posttraumatic stress symptoms 5 to 6 years following exposure to the World Trade Center terrorist attack. Jama 302:5 (2009), 502–516.
3. Burton, C.L., Galatzer-Levy, I.R., Bonanno, G.A., Treatment type and demographic characteristics as predictors for cancer adjustment: prospective trajectories of depressive symptoms in a population sample. Health Psychol., 34(6), 2015, 602.
4. Canetti, D., Russ, E., Luborsky, J., Gerhart, J.I., Hobfoll, S.E., Inflamed by the flames? The impact of terrorism and war on immunity. J. Trauma. stress 27:3 (2014), 345–352.
5. Cox, B.J., Clara, I.P., Enns, M.W., Posttraumatic stress disorder and the structure of common mental disorders. Depress Anxiety 15:4 (2002), 168–171.
6. Daskalakis, N.P., Lehrner, A., Yehuda, R., Endocrine aspects of post-traumatic stress disorder and implications for diagnosis and treatment. Endocrinol. Metab. Clin. North Am. 42:3 (2013), 503–513.
7. Derogatis, L.R., Lipman, R.S., Rickels, K., Uhlenhuth, E.H., Covi, L., The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav. Sci. 19:1 (1974), 1–15.
8. DiGrande, L., Perrin, M.A., Thorpe, L.E., Thalji, L., Murphy, J., Wu, D., Farfel, M., Brackbill, R.M., Posttraumatic stress symptoms, PTSD, and risk factors among lower Manhattan residents 2-3 years after the September 11, 2001 terrorist attacks. J. Trauma. stress 21:3 (2008), 264–273.
9. Eraly, S.A., Nievergelt, C.M., Maihofer, A.X., Barkauskas, D.A., Biswas, N., Agorastos, A., O'Connor, D.T., Baker, D.G., Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA psychiatry 71:4 (2014), 423–431.
10. Eyre, H.A., Lavretsky, H., Kartika, J., Qassim, A., Baune, B.T., Modulatory effects of antidepressant classes on the innate and adaptive immune system in depression. Pharmacopsychiatry 49:3 (2016), 85–96.
11. Farfel, M., DiGrande, L., Brackbill, R., Prann, A., Cone, J., Friedman, S., Walker, D.J., Pezeshki, G., Thomas, P., Galea, S., Williamson, D., Frieden, T.R., Thorpe, L., An overview of 9/11 experiences and respiratory and mental health conditions among World Trade Center Health Registry enrollees. J. urban health Bull. N. Y. Acad. Med. 85:6 (2008), 880–909.
12. Farr, O.M., Sloan, D.M., Keane, T.M., Mantzoros, C.S., Stress-and PTSD-associated obesity and metabolic dysfunction: a growing problem requiring further research and novel treatments. Metabolism Clin. Exp. 63:12 (2014), 1463–1468.
13. Flory, J.D., Yehuda, R., Comorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerations. Dialogues Clin. Neurosci. 17:2 (2015), 141–150.
14. Friedman, S.M., Farfel, M.R., Maslow, C.B., Cone, J.E., Brackbill, R.M., Stellman, S.D., Comorbid persistent lower respiratory symptoms and posttraumatic stress disorder 5-6 years post-9/11 in responders enrolled in the World Trade Center Health Registry. Am. J. industrial Med. 56:11 (2013), 1251–1261.
15. Furtado, M., Katzman, M.A., Examining the role of neuroinflammation in major depression. Psychiatry Res. 229:1–2 (2015), 27–36.
16. Galatzer-Levy, I.R., Bonanno, G.A., Optimism and Death Predicting the Course and Consequences of Depression Trajectories in Response to Heart Attack. Psychological science, 0956797614551750, 2014.
17. Galatzer-Levy, I.R., Bryant, R.A., 636,120 ways to have posttraumatic stress disorder. Perspect. Psychol. Sci. 8:6 (2013), 651–662.
18. Galatzer-Levy, I.R., Nickerson, A., Litz, B.T., Marmar, C.R., Patterns of lifetime PTSD comorbidity: a latent class analysis. Depress Anxiety 30:5 (2013), 489–496.
19. Gill, J.M., Saligan, L., Woods, S., Page, G., PTSD is associated with an excess of inflammatory immune activities. Perspect. psychiatric care 45:4 (2009), 262–277.
20. Haroon, E., Raison, C.L., Miller, A.H., Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37:1 (2012), 137–162.
21. Howren, M.B., Lamkin, D.M., Suls, J., Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 71:2 (2009), 171–186.
22. Kaptoge, S., Di Angelantonio, E., Lowe, G., Pepys, M.B., Thompson, S.G., Collins, R., Danesh, J., The Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-anlysis. Lancet 375:9709 (2010), 132–140.
23. Kazeros, A., Zhang, E., Cheng, X., Shao, Y., Liu, M., Qian, M., Caplan-Shaw, C., Berger, K.I., Goldring, R.M., Ghumman, M., Chokshi, N.P., Levy-Carrick, N., Fernandez-Beros, M.E., Parsia, S., Marmor, M., Reibman, J., Systemic inflammation associated with world trade center dust exposures and airway abnormalities in the local community. J. Occup. Environ. Med./Am. Coll. Occup. Environ. Med. 57:6 (2015), 610–616.
24. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Merikangas, K.R., Walters, E.E., Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey replication. Arch. Gen. Psychiatry 62:6 (2005), 593–602.
25. Khairova, R.A., Machado-Vieira, R., Du, J., Manji, H.K., A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int. J. Neuropsychopharmacol. 12:4 (2009), 561–578.
26. Lin, S., Jones, R., Reibman, J., Bowers, J., Fitzgerald, E.F., Hwang, S.A., Reported respiratory symptoms and adverse home conditions after 9/11 among residents living near the World Trade Center. J. asthma official J. Assoc. Care Asthma 44:4 (2007), 325–332.
27. Lin, S., Reibman, J., Bowers, J.A., Hwang, S.-A., Hoerning, A., Gomez, M.I., Fitzgerald, E.F., Upper respiratory symptoms and other health effects among residents living near the world trade center site after September 11, 2001. Am. J. Epidemiol. 162:6 (2005), 499–507.
28. Lioy, P.J., Georgopoulos, P., The anatomy of the exposures that occurred around the World Trade Center site: 9/11 and beyond. Ann. N. Y. Acad. Sci. 1076 (2006), 54–79.
29. Lippmann, M., Cohen, M.D., Chen, L.C., Health effects of World Trade Center (WTC) Dust: an unprecedented disaster's inadequate risk management. Crit. Rev. Toxicol. 45:6 (2015), 492–530.
30. Liu, M., Qian, M., Cheng, Q., Berger, K.I., Shao, Y., Turetz, M., Kazeros, A., Parsia, S., Goldring, R.M., Caplan-Shaw, C., Elena Fernandez-Beros, M., Marmor, M., Reibman, J., Longitudinal spirometry among patients in a treatment program for community members with World Trade Center-related illness. J. Occup. Environ. Med. 54:10 (2012), 1208–1213.
31. Marshall, G.N., Schell, T.L., Miles, J.N., A multi-sample confirmatory factor analysis of PTSD symptoms: what exactly is wrong with the DSM-IV structure?. Clin. Psychol. Rev. 33:1 (2013), 54–66.
32. Maslow, C.B., Friedman, S.M., Pillai, P.S., Reibman, J., Berger, K.I., Goldring, R., Stellman, S.D., Farfel, M., Chronic and acute exposures to the world trade center disaster and lower respiratory symptoms: area residents and workers. Am. J. Public Health 102:6 (2012), 1186–1194.
33. McAfoose, J., Baune, B., Evidence for a cytokine model of cognitive function. Neurosci. Biobehav. Rev. 33:3 (2009), 355–366.
34. McCanlies, E.C., Araia, S.K., Joseph, P.N., Mnatsakanova, A., Andrew, M.E., Burchfiel, C.M., Violanti, J.M., C-reactive protein, interleukin-6, and posttraumatic stress disorder symptomology in urban police officers. Cytokine 55:1 (2011), 74–78.
35. Michopoulos, V., Powers, A., Gillespie, C.F., Ressler, K.J., Jovanovic, T., Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology 42:1 (2017), 254–270.
36. Michopoulos, V., Rothbaum, A.O., Jovanovic, T., Almli, L.M., Bradley, B., Rothbaum, B.O., Gillespie, C.F., Ressler, K.J., Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma. Am. J. Psychiatry 172:4 (2015), 353–362.
37. Miller, A.H., Maletic, V., Raison, C.L., Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. psychiatry 65:9 (2009), 732–741.
38. Miller, R.J., Sutherland, A.G., Hutchison, J.D., Alexander, D.A., C-reactive protein and interleukin 6 receptor in post-traumatic stress disorder: a pilot study. Cytokine 13:4 (2001), 253–255.
39. Norrholm, S.D., Glover, E.M., Stevens, J.S., Fani, N., Galatzer-Levy, I.R., Bradley, B., Ressler, K.J., Jovanovic, T., Fear load: the psychophysiological over-expression of fear as an intermediate phenotype associated with trauma reactions. Int. J. Psychophysiol. 98:2 Pt 2 (2015), 270–275.
40. Olbert, C.M., Gala, G.J., Tupler, L.A., Quantifying heterogeneity attributable to polythetic diagnostic criteria: theoretical framework and empirical application. J. Abnorm Psychol. 123:2 (2014), 452–462.
41. Passos, I.C., Vasconcelos-Moreno, M.P., Costa, L.G., Kunz, M., Brietzke, E., Quevedo, J., Salum, G., Magalhães, P.V., Kapczinski, F., Kauer-Sant'Anna, M., Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry 2:11 (2015), 1002–1012.
42. Pitman, R.K., Rasmusson, A.M., Koenen, K.C., Shin, L.M., Orr, S.P., Gilbertson, M.W., Milad, M.R., Liberzon, I., Biological studies of post-traumatic stress disorder. Nat. Rev. Neurosci. 13:11 (2012), 769–787.
43. Ransohoff, R.M., Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity 31:5 (2009), 711–721.
44. Reibman, J., Levy-Carrick, N., Miles, T., Flynn, K., Hughes, C., Crane, M., Lucchini, R.G., Destruction of the World Trade Towers: Lessons Learned from an Environmental Health Disaster. 2016, Annals of the American Thoracic Society.
45. Reibman, J., Lin, S., Hwang, S.-A.A., Gulati, M., Bowers, J.A., Rogers, L., Berger, K.I., Hoerning, A., Gomez, M., Fitzgerald, E.F., The World Trade Center residents' respiratory health study: new-onset respiratory symptoms and pulmonary function. Environ. health Perspect., 2005, 406–411.
46. Reibman, J., Liu, M., Cheng, Q., Liautaud, S., Rogers, L., Lau, S., Berger, K.I., Goldring, R.M., Marmor, M., Fernandez-Beros, M.E., Tonorezos, E.S., Caplan-Shaw, C.E., Gonzalez, J., Filner, J., Walter, D., Kyng, K., Rom, W.N., Characteristics of a residential and working community with diverse exposure to World Trade Center dust, gas, and fumes. J. Occup. Environ. Med./Am. Coll. Occup. Environ. Med. 51:5 (2009), 534–541.
47. Rogowski, O., Vered, Y., Shapira, I., Hirsh, M., Zakut, V., Berliner, S., Introducing the wide range C-reactive protein (wr-CRP) into clinical use for the detection of microinflammation. Clin. Chim. Acta 358:1–2 (2005), 151–158.
48. Söndergaard, H.P., Hansson, L.-O., Theorell, T., The inflammatory markers C-reactive protein and serum amyloid A in refugees with and without posttraumatic stress disorder. Clin. Chim. acta 342:1 (2004), 93–98.
49. Valkanova, V., Ebmeier, K.P., Allan, C.L., CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J. Affect Disord. 150:3 (2013), 736–744.
50. von Känel, R., Hepp, U., Kraemer, B., Traber, R., Keel, M., Mica, L., Schnyder, U., Evidence for low-grade systemic proinflammatory activity in patients with posttraumatic stress disorder. J. psychiatric Res. 41:9 (2007), 744–752.
51. Weathers FW, L.B., Herman, D.S., Huska, J.A., Keane, T.M., The PTSD Checklist (PCL): Reliability, Validity, and Diagnostic Utility. 1993, International Society for Truamatic Stress Studies.
52. Yeh, E.T., Willerson, J.T., Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation 107:3 (2003), 370–371.
53. Yehuda, R., LeDoux, J., Response variation following trauma: a translational neuroscience approach to understanding PTSD. Neuron 56:1 (2007), 19–32.
54. Yirmiya, R., Goshen, I., Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain, Behav. Immun. 25:2 (2011), 181–213.
55. Zhu, Z., Galatzer-Levy, I.R., Bonanno, G.A., Heterogeneous depression responses to chronic pain onset among middle-aged adults: a prospective study. Psychiatry Res. 217:1 (2014), 60–66.